These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3856564)

  • 1. Simultaneous simulation of two different concentration time curves in vitro.
    Shah PM
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():261-4. PubMed ID: 3856564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory evaluation of cefmenoxime: a new cephalosporin. In vitro and in vivo antibacterial activities and pharmacokinetic properties.
    Matsumoto K; Nagatake T; Uzuka Y; Harada T; Rikitomi N
    Chemotherapy; 1983; 29(2):80-8. PubMed ID: 6301776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic considerations for the setting of in-vitro models.
    Lintz W
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():85-97. PubMed ID: 3980340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the prostatic tissue levels of cefmenoxime (CMX)].
    Kataoka K; Kaneko S; Kurita T
    Hinyokika Kiyo; 1985 Feb; 31(2):273-9. PubMed ID: 2409786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transfer of cefmenoxime to burn blister fluids].
    Nishizaki A; Aoyama H; Koh T; Izawa Y
    Jpn J Antibiot; 1984 Mar; 37(3):295-302. PubMed ID: 6330396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the diffusion of cefmenoxime into the bronchial secretions.
    Serieys C; Bergogne-Berezin E; Kafe H; Bryskier A
    Chemotherapy; 1986; 32(1):1-6. PubMed ID: 3456295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic study of cefmenoxime concerning its transfer into tissues].
    Washida H; Tsugaya M; Hirao N; Sakagami H; Iwase Y
    Jpn J Antibiot; 1985 Jun; 38(6):1648-53. PubMed ID: 3862883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Campoli-Richards DM; Todd PA
    Drugs; 1987 Aug; 34(2):188-221. PubMed ID: 3304966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of cefmenoxime in the aged subject (60 to 90 years of age) after an intravenous injection of 1 g].
    Veyssier P; Bryskier A; Modai J; Boquet A; Fourtillan JB
    Pathol Biol (Paris); 1986 Dec; 34(10):1081-3. PubMed ID: 3547264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives.
    Blaser J
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():125-30. PubMed ID: 3980323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study on cefmenoxime (CMX) in urology].
    Tanaka H; Kato Y; Kakinoki K; Nishio S; Maekawa M; Tsujita M; Nishijima T; Kashihara N; Kono S; Hayahara N
    Hinyokika Kiyo; 1983 Jan; 29(1):95-103. PubMed ID: 6328956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of cefmenoxime, cefotaxime, latamoxef, cefazolin, nafcillin and vancomycin against 53 endocarditis and bacteremic strains of Staphylococcus aureus.
    Dhawan VK; Maier MK; Nayyar M; Chuah SK; Thadepalli H
    Chemotherapy; 1984; 30(5):328-30. PubMed ID: 6092007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of SCE-1141, a stereoisomer of cefmenoxime, in rats.
    Kita Y; Itakura K; Tsuchiya K; Imada A
    J Antimicrob Chemother; 1986 Feb; 17(2):205-13. PubMed ID: 3457784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies on cefmenoxine concentration in prostatic tissue and bladder wall].
    Miyagawa I; Goto H; Nakashita E; Fukuda K; Hamamoto R; Inoue A; Miyake S; Nishida H; Umano I; Nakamura I
    Jpn J Antibiot; 1984 May; 37(5):787-90. PubMed ID: 6090720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of Cefmenoxime in normal and impaired renal function.
    Höffler D; Koeppe P
    Arzneimittelforschung; 1983; 33(2):269-72. PubMed ID: 6303362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concentrations of cefmenoxime and cefotiam in the bile and gallbladder tissue following intravenous administration in patients with biliary tract diseases].
    Shoda Y; Matsuyama S; Takarada A; Arai M; Nagashima K; Nakano G; Nakamura T; Kamisaka K; Matsuzawa T; Yoshino T
    Jpn J Antibiot; 1986 May; 39(5):1259-72. PubMed ID: 3463776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Penetration of cefmenoxime into pleural fluid].
    Miyazaki N; Kajiki A; Yamazaki H; Harada S; Kido M; Kuroiwa A
    Jpn J Antibiot; 1984 Oct; 37(10):1763-5. PubMed ID: 6094856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of cefmenoxime in acute peritonitis: clinical effect and tissue concentration of cefmenoxime].
    Hashimoto I; Sawada Y; Nakamura T; Mikami J; Bekki E; Abe H; Nakanishi M; Kasai Y
    Jpn J Antibiot; 1983 Jun; 36(6):1544-52. PubMed ID: 6317906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro study of the synergistic effect of cefmenoxime-aminoglycoside combinations apropos of 148 strains of Enterobacteriaceae].
    Husson MO; Izard D; Bryskier A; Leclerc H
    Pathol Biol (Paris); 1984 May; 32(5):396-8. PubMed ID: 6330651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of cefmenoxime in the pediatric infections].
    Meguro H; Ozawa S; Togo T; Hiraiwa M; Kim B; Fujii R
    Jpn J Antibiot; 1982 Oct; 35(10):2405-13. PubMed ID: 6306292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.